SSG
BSX icon

Summit Securities Group’s Boston Scientific BSX Stock Holding History

Summit Securities Group’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-200
Closed -$707K – 211
2018
Q4 		$707K Buy
+200
New +$7.25K 0.06% 172

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Summit Securities Group's BSX Position: Q2 2026 in Review

Summit Securities Group reduced its Boston Scientific (BSX) stake by 97% in Q2 2026, selling an estimated $619K and leaving 344 shares worth $14.7K. The position accounts for ﹤0.01% of the portfolio, ranked #782.

Summit Securities Group first reported a position in BSX in Q4 2018 and has held it in 11 quarters since. The position peaked at $737K in Q1 2026. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Summit Securities Group held 344 shares of Boston Scientific worth $14.7K as of Q2 2026.
  • Summit Securities Group sold 11,400 Boston Scientific shares in Q2 2026, an estimated $619K.
  • Boston Scientific made up ﹤0.01% of Summit Securities Group's portfolio in Q2 2026, its #782 holding.
  • Summit Securities Group first reported a position in Boston Scientific in Q4 2018 and has held it in 11 quarters since.
  • Summit Securities Group's Boston Scientific position peaked at $737K in Q1 2026.
  • 1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Summit Securities Group's 13F filing for Q2 2026, filed 3 Aug 2026.